In 2021 Omeros Corporation (OMER) delivered great results, net income was $194.2 million or $3.12 per share VS a net loss of $138.1 million or $2.41 net loss per share in 2020. On 1/18/2022 Cantor Fitzgerald Lower Price Target for OMER from $34.00 to $20.00. I think a reversal to the $8.50 resistance is possible. Looking forward to read your opinion about it.
Biologics License Application for Narsoplimab in HSCT-TMA Accepted for Priority Review by U.S. FDA -- FDA sets PDUFA date of July 17, 2021 --
While trading within a well defined trend, touching the resistance of the trend the stock rushed down and currently consolidates with a low change (compared to the previous 2 day selloff) at a strong resistance point. Should resistance hold, it is possible to break up to 19. As Vince noted, once it broke off the 14 range, it went straight up to 18. Yet still, the...